Decreased cerebrospinal fluid amyloid beta (1–40) levels in frontotemporal lobar degeneration
Decreased cerebrospinal fluid amyloid beta (1–40) levels in frontotemporal lobar degeneration
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
The role of amyloid metabolism in the pathophysiology of frontotemporal lobar degeneration (FTLD) has yet to be elucidated. We compared CSF levels of amyloid beta 1–40 (Aβ40) and amyloid beta 1–42 (Aβ42) in patients with FTLD (n = 21) versus patients with Alzheimer’s disease (AD, n = 39) and in control subjects (n = 30). While in AD cases Aβ42 leve...
Alternative Titles
Full title
Decreased cerebrospinal fluid amyloid beta (1–40) levels in frontotemporal lobar degeneration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117666
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2117666
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp.2006.105064
